Skip to main content
. 2014 Jan 22;15(1):6. doi: 10.1186/1465-9921-15-6

Table 1.

Patient demographics

Characteristic, n (%) Early responders n = 332 Later responders n = 253 Patients without Halm-based assessment of TCS n = 1454
Age, years, mean (SD) [median]
63.8 (19.0) [68]
64.5 (18.2) [69]
64.7 (18.5) [68]
 ≥ 65 years
187 (55.8)
137 (54.2)
827 (56.9)
Sex, male
204 (61.4)
144 (56.9)
848 (58.3)
Ethnic origin
 White
225 (67.8)
217 (85.8)
1131 (77.8)
 Non-white
8 (2.4)
3 (1.2)
40 (2.8)
 Unknown/missing
9 (2.7)
3 (1.2)
39 (2.7)
 Not applicable*
90 (27.1)
30 (11.9)
244 (16.8)
Previous admission to hospital with CAP (last 3 months)
8 (2.4)
9 (3.6)
82 (5.6)
Haemodialysis
0
1 (0.4)
5 (0.3)
Chemotherapy for active cancer
1 (0.3)
1 (0.4)
28 (1.9)
Smoking status
 Non-smoker
129 (38.5)
108 (42.7)
467 (32.1)
 Ex-smoker
94 (28.1)
79 (31.2)
380 (26.1)
 Occasional smoker
2 (0.6)
2 (0.8)
38 (2.6)
 Habitual smoker
89 (26.8)
46 (18.2)
328 (22.6)
 Unknown 18 (5.4) 18 (7.1) 241 (16.6)

*All patients in this category were from France, where this question is not permitted in clinical studies.

Definitions: Never smoked: patients who have never smoked > 20 g of tobacco in their lifetime; Ex-smoker: patients who stopped smoking ≥ 365 days ago: Occasional smoker: patients who smoke < 1 tobacco product per day; Habitual smoker: patients who smoke ≥ 1 tobacco products/day.

SD = standard deviation; TCS = time to clinical stability.